Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares rose as much as 9% during Friday’s trading session, after the drug maker announced changes to its ongoing Ocaliva …
Cowen analyst Ritu Baral weighs in today on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), after the drug maker provided an update focusing on the ongoing launch of …
In a research report published Tuesday, Cowen analyst Ritu Baral reiterated an Outperform rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), with a …
Cempra Inc (NASDAQ:CEMP) shares collapsed 57% yesterday after the firm received a Complete Response Letter (CRL) from the FDA for its pipeline drug …
Cowen analyst Ritu Baral is chiming in with her two cents on Sarepta Therapeutics Inc (NASDAQ:SRPT) as to what the early days of …
Cowen analyst Ritu Baral is out with a research report on shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after conducting separate surveys of 25 …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is anticipated to announce data from the Phase 2 trial of pimavanserin in Alzheimer’s Disease Psychosis (ADP) come December.
After Amicus Therapeutics, Inc. (NASDAQ:FOLD) met with the FDA and received written minutes, the biotech firm revealed yesterday that with the present data …
Cempra Inc (NASDAQ:CEMP) seen its shares falling nearly 9% (as of this writing), after analyst Ritu Baral of investment banking firm Cowen has downgraded CEMP …
Amicus Therapeutics, Inc. (NASDAQ:FOLD) shares jumped over 20% today after the drug maker released its third-quarter results, posting EPS of $(0.
